V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20207962 | 20077681 | 0 | 0 | Palliative (P) | 2019-06-06 | 2019-07-03 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101745712 |
| 20207974 | 20077682 | 0 | 77.45 | 03 | 2019-07-28 | 2019-07-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101266249 |
| 20207977 | 20077683 | 1.76 | 61.5 | Adjuvant (A) | 2018-09-04 | 2018-09-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100071484 |
| 20207982 | 20077684 | 1.59 | 83.6 | Neo-adjuvant (N) | 2018-09-03 | 2018-09-07 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101637897 |
| 20207987 | 20077685 | 1.73 | 57.05 | Palliative (P) | 2020-08-21 | 2020-09-05 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100843813 |
| 20207988 | 20077686 | 1.72 | 51.3 | null | 2017-09-01 | 2017-09-17 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 100114732 |
| 20207993 | 20077687 | 1.76 | 79 | 03 | 2019-10-09 | 2019-10-16 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 100079544 |
| 20208000 | 20077688 | 1.66 | 100.8 | Palliative (P) | 2016-02-17 | 2016-03-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100930751 |
| 20208003 | 20077689 | 1.77 | null | Palliative (P) | 2020-01-16 | 2020-01-31 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 101258373 |
| 20208005 | 20077690 | 1.48 | 46.3 | Palliative (P) | null | 2017-09-30 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100004920 |
| 20208009 | 20077691 | 1.73 | 102 | null | 2017-01-17 | 2017-01-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101741277 |
| 20208015 | 20077692 | 1.75 | 71 | Curative (C) | 2016-12-29 | 2017-01-19 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 101575468 |
| 20208016 | 20077693 | 1.68 | 56.4 | Curative (C) | 2016-02-09 | 2016-02-11 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100662103 |
| 20208023 | 20077694 | 1.67 | 56.15 | null | 2016-05-04 | 2016-06-07 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101213156 |
| 20208029 | 20077695 | 1.74 | 81.2 | null | 2018-08-07 | 2018-08-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101504267 |
| 20208032 | 20077696 | 1.87 | 68 | 03 | 2017-05-29 | 2017-06-05 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100780755 |
| 20208036 | 20077697 | 1.72 | 70.8 | Palliative (P) | 2017-04-10 | 2017-05-06 | CISPLATIN + FLUOROURACIL + RT | null | N | CISPLATIN + FLUOROURACIL | 100757471 |
| 20208038 | 20077698 | 1.54 | 77.4 | Palliative (P) | 2020-01-14 | 2020-01-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101648774 |
| 20208039 | 20077699 | 1.72 | 66 | Palliative (P) | null | 2016-09-11 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100244413 |
| 20208043 | 20077700 | 1.72 | 70.3 | Palliative (P) | 2019-10-01 | 2019-11-22 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100755249 |
| 20208046 | 20077701 | 1.78 | null | null | 2017-04-22 | 2017-05-06 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100387775 |
| 20208048 | 20077702 | 1.7 | null | Palliative (P) | 2018-12-04 | 2018-12-05 | Capecitabine + Carboplatin + RT | 02 | null | TRIAL UNSPECIFIED | 101311813 |
| 20208052 | 20077703 | 1.7 | 60 | null | 2019-03-16 | 2019-03-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100104189 |
| 20208054 | 20077704 | 0 | 0 | Curative (C) | 2019-08-31 | 2019-09-21 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100276301 |
| 20208055 | 20077705 | 1.85 | 62.55 | Curative (C) | 2016-04-28 | 2016-04-28 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 100248215 |
| 20208059 | 20077706 | 1.63 | 71.3 | Palliative (P) | 2018-10-26 | 2018-10-28 | Capecitabine + Carboplatin + RT | 02 | N | TRIAL UNSPECIFIED | 100932119 |
| 20208070 | 20077707 | 0 | 0 | 03 | 2020-08-24 | 2020-10-05 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101457013 |
| 20208079 | 20077708 | 1.7 | 51.8 | null | 2017-07-21 | 2017-07-27 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101607382 |
| 20208081 | 20077709 | 1.77 | 86.45 | Palliative (P) | 2018-10-14 | 2018-11-18 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101478659 |
| 20208082 | 20077710 | 1.67 | 57.9 | Palliative (P) | 2019-02-12 | 2019-02-21 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100422530 |
| 20208083 | 20077711 | null | 71.8 | Curative (C) | 2018-07-19 | 2018-08-05 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101456912 |
| 20208088 | 20077712 | 1.53 | 47.7 | Curative (C) | 2018-04-26 | 2018-05-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101730135 |
| 20208089 | 20077713 | 0 | 0 | Neo-adjuvant (N) | 2018-09-07 | 2018-10-01 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101244094 |
| 20208092 | 20077714 | 1.74 | 71.5 | null | 2016-11-07 | 2016-11-15 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101548781 |
| 20208094 | 20077715 | 1.71 | 68.4 | Curative (C) | 2019-08-05 | 2019-08-05 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101121455 |
| 20208097 | 20077716 | 1.73 | 60 | Neo-adjuvant (N) | 2016-07-03 | 2016-07-06 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101282007 |
| 20208099 | 20077717 | 0 | 0 | Palliative (P) | null | 2017-04-29 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100614391 |
| 20208100 | 20077718 | 1.69 | 50.7 | Palliative (P) | 2017-06-02 | 2017-06-27 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100182868 |
| 20208101 | 20077719 | 1.66 | 106 | Palliative (P) | 2017-11-17 | 2017-12-17 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101781809 |
| 20208105 | 20077720 | 1.77 | 82.7 | Neo-adjuvant (N) | 2019-09-19 | 2019-09-30 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100941235 |
| 20208106 | 20077721 | 1.62 | 83.2 | Neo-adjuvant (N) | 2016-03-07 | 2016-05-01 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101499360 |
| 20208110 | 20077722 | 1.85 | 73.3 | Curative (C) | 2018-06-25 | 2018-07-06 | Capecitabine (21days) + Carboplatin | N | Y | CISPLATIN + FLUOROURACIL | 101687696 |
| 20208112 | 20077723 | 1.68 | 73.95 | Curative (C) | null | 2016-12-17 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100626452 |
| 20208115 | 20077724 | 1.61 | 95.25 | Palliative (P) | 2017-06-04 | 2017-06-07 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100038375 |
| 20208116 | 20077725 | 1.82 | 67.8 | Neo-adjuvant (N) | 2020-02-26 | 2020-02-26 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100308771 |
| 20208118 | 20077726 | 1.73 | 82.4 | null | 2018-02-28 | 2018-03-08 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101520572 |
| 20208119 | 20077727 | 1.8 | 62.5 | Curative (C) | 2020-04-05 | 2020-04-12 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100136646 |
| 20208130 | 20077728 | 1.75 | 82.7 | Palliative (P) | 2019-07-12 | 2019-07-13 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100112407 |
| 20208134 | 20077729 | 1.6 | 79.7 | Palliative (P) | 2018-09-02 | 2018-09-02 | CAPECITABINE + CARBOPLATIN | 2 | N | CAPECITABINE + CARBOPLATIN | 101158104 |
| 20208139 | 20077730 | 1.73 | 64.75 | Palliative (P) | 2020-01-12 | 2020-02-13 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100193229 |